No abstract available
MeSH terms
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal / therapeutic use
-
Antirheumatic Agents / adverse effects*
-
Antirheumatic Agents / therapeutic use
-
Arthritis, Rheumatoid / drug therapy
-
Aspergillus / isolation & purification
-
Bronchoalveolar Lavage
-
Cryptogenic Organizing Pneumonia / chemically induced
-
Cryptogenic Organizing Pneumonia / diagnosis
-
Cryptogenic Organizing Pneumonia / pathology
-
Humans
-
Infliximab
-
Lung Diseases, Interstitial / chemically induced*
-
Lung Diseases, Interstitial / diagnosis
-
Lung Diseases, Interstitial / pathology
-
Mast Cells / microbiology
-
Mast Cells / pathology
-
Methotrexate / adverse effects
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Substances
-
Antibodies, Monoclonal
-
Antirheumatic Agents
-
Tumor Necrosis Factor-alpha
-
Infliximab
-
Methotrexate